Futurefuel (FF) Q3 2026 Earnings Report

The call was broadly optimistic, with strong biofuel utilization and demand, significant revenue growth, improved Chemicals segment gross profit, completed maintenance work, new reshoring opportunities and customer-funded expansion investments. These positives were partly offset by third-quarter gross and net losses, elevated feedstock costs, lower Chemicals utilization, derivative losses and reduced cash balances. Management nevertheless characterized the short-term disruptions as resolved and expressed confidence in a solid end to 2026 and a strong start to 2027.

Management expects biodiesel demand to further accelerate entering 2027, with more than 9% of fourth quarter biodiesel production capacity already booked, and expects sales volumes to remain high entering the fourth quarter and into 2027; it expects to sell $1.5 million of RINs and recover $2.3 million in derivative losses in the fourth quarter. The company expects a solid end to 2026 and a strong start heading into next year, with no major planned maintenance scheduled through the first quarter of 2027, fourth quarter Chemical segment capacity utilization above prior year levels, initial batch production for a new European chemicals customer in the first quarter of 2027 and full production rates mid-2027, and a potential $5 million to $10 million opportunity from refined glycerin beginning in 2027, requiring less than $1 million in CapEx, with operations up and running by the end of Q4 and running all through 2027. FutureFuel is focused on building its cash position back to $50 million over the next year, expects customers to invest another $15 million to $20 million in its Batesville site between 2028 and 2029, and expects to run its large methacrylate plant at probably closer to 70% capacity utilization in 2027 versus 50% this year.